Live attenuated Salmonella displaying HIV-1 10E8 epitope on fimbriae: systemic and mucosal immune responses in BALB/c mice by mucosal administration

被引:0
|
作者
Qing-Hai Li
Gang Jin
Jia-Ye Wang
Hai-Ning Li
Huidi Liu
Xiao-Yun Chang
Fu-Xiang Wang
Shu-Lin Liu
机构
[1] Systemomics Center,Department of Microbiology
[2] College of Pharmacy and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China),Department of Infectious Diseases
[3] Harbin Medical University,Department of Infectious Diseases
[4] Harbin Medical University,Department of Microbiology
[5] The Fourth Affiliated Hospital of Harbin Medical University,undefined
[6] The First Affiliated Hospital,undefined
[7] Harbin Medical University,undefined
[8] Immunology and Infectious Diseases,undefined
[9] University of Calgary,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The HIV-1 membrane proximal external region (MPER) that is targeted by several broadly neutralizing antibodies (BNAbs) has been considered a potential immunogen for vaccine development. However, to date the immunogenicity of these BNAb epitopes has not been made sufficiently adequate. In the present work, we used live attenuated Salmonella as a platform to present the HIV-1 MPER 10E8 epitope in the fimbriae. The insertion of the 10E8 epitope into the fimbriae had no significant influence on the expression and the absorption capacity of bacterial fimbriae, nor on the virulence and invasiveness of the attenuated Salmonella. After oral administration of the vaccine construct to mice followed by 10E8 epitope peptide boost, specific antibody responses in serum and mucosa as well as memory lymphocytes in spleen and plasma cells in bone marrow were induced. We also found that the live attenuated Salmonella vector directed the immunity toward Th1 bias, induced Th1 and Th2 cytokine responses and stimulated significant B cell differentiation into GC B, memory B and plasma cells. Therefore, we propose that the live attenuated Salmonella constitutively expressing HIV-1 BNAb epitopes on the fimbriae will be an effective approach to improving immune microenvironment and enhancing the immunogenicity of HIV-1 epitope vaccines.
引用
收藏
相关论文
共 50 条
  • [41] A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques
    Egan, MA
    Chong, SY
    Hagen, M
    Megati, S
    Schadeck, EB
    Piacente, P
    Ma, BJ
    Montefiori, DC
    Haynes, BF
    Israel, ZR
    Eldridge, JH
    Staats, HF
    VACCINE, 2004, 22 (27-28) : 3774 - 3788
  • [42] The mucosae-associated epithelial chemokine (CCL28) modulates mucosal immunity in balb/c mice immunized with HIV-1 virus like particles
    Rainone, V.
    Ueberla, K.
    Temchura, V.
    Trabattoni, D.
    Clivio, A.
    Veas, F.
    Nebuloni, M.
    Clerici, M.
    INFECTION, 2010, 38 : 39 - 40
  • [43] A Novel, Live-Attenuated Vesicular Stomatitis Virus Vector Displaying Conformationally Intact, Functional HIV-1 Envelope Trimers That Elicits Potent Cellular and Humoral Responses in Mice
    Rabinovich, Svetlana
    Powell, Rebecca L. R.
    Lindsay, Ross W. B.
    Yuan, Maoli
    Carpov, Alexei
    Wilson, Aaron
    Lopez, Mary
    Coleman, John W.
    Wagner, Denise
    Sharma, Palka
    Kemelman, Marina
    Wright, Kevin J.
    Seabrook, John P.
    Arendt, Heather
    Martinez, Jennifer
    DeStefano, Joanne
    Chiuchiolo, Maria J.
    Parks, Christopher L.
    PLOS ONE, 2014, 9 (09):
  • [44] A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors
    Bermúdez-Humarán, LG
    Cortes-Perez, NG
    Lefèvre, F
    Guimaraes, V
    Rabot, S
    Alcocer-Gonzalez, JM
    Gratadoux, JJ
    Rodriguez-Padilla, C
    Tamez-Guerra, RS
    Corthier, G
    Gruss, A
    Langella, P
    JOURNAL OF IMMUNOLOGY, 2005, 175 (11): : 7297 - 7302
  • [45] Intragastric immunization with recombinant H-pylori urease formulated with attenuated cholera toxin elicits systemic, mucosal and protective immune responses in C57BL/6 mice
    Zhu, D
    Schmidt, S
    Fulginiti, J
    Fiske, M
    Phillips, E
    Peek, J
    Green, B
    Eldridge, JH
    FASEB JOURNAL, 1999, 13 (04): : A291 - A291
  • [46] Chimeric Nod2/TLR2 Ligand Amplifies HIV-1 Gag p24-specific Mucosal and Systemic Immune Responses after Sub Cutaneous Immunization in Mice
    Phelip, Capucine
    Pavot, Vincent
    Rochereau, Nicolas
    Perouzel, Eric
    Lioux, Thierry
    Tiraby, Gerard
    Primard, Charlotte
    Paul, Stephane
    Verrier, Bernard
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A195 - A195
  • [47] Mucosal and systemic HIV-1 Env-specific CD8+ T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector
    Shata, MT
    Reitz, MS
    DeVico, AL
    Lewis, GK
    Hone, DM
    VACCINE, 2001, 20 (3-4) : 623 - 629
  • [48] Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector
    Wu, SG
    Pascual, DW
    Lewis, GK
    Hone, DM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (14) : 1187 - 1194
  • [49] Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8
    Sutar, Jyoti
    Padwal, Varsha
    Sonawani, Archana
    Nagar, Vidya
    Patil, Priya
    Kulkarni, Bhalachandra
    Hingankar, Nitin
    Deshpande, Suprit
    Idicula-Thomas, Susan
    Jagtap, Dhanashree
    Bhattacharya, Jayanta
    Bandivdekar, Atmaram
    Patel, Vainav
    VIRUS RESEARCH, 2019, 273
  • [50] Feeding of mice with Arabidopsis thaliana expressing the HIV-1 subtype C p24 antigen gives rise to systemic immune responses
    Lindh, Ingrid
    Kalbina, Irina
    Thulin, Sara
    Scherbak, Nikolai
    Savenstrand, Helena
    Brave, Andreas
    Hinkula, Jorma
    Strid, Ake
    Andersson, Soren
    APMIS, 2008, 116 (11) : 985 - 994